ArticleScientific reports2022

Rituximab with high-dose methotrexate is effective and cost-effective in newly diagnosed primary central nervous system lymphoma.

Xianggui Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.